Follow the people · Insider
Jennifer E. Cook
Jennifer E. Cook files insider transactions with the SEC as a director of Jazz Pharmaceuticals (JAZZ). We hold 4 disclosed purchases and sales filed since 8 November 2018, 4 of them in the last 90 days.
- Files forJAZZ
- Disclosed buys and sells4 in all, 4 in the last 90 days
- Last disclosure2 September 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 25 February 2021 — 31 August 2026Director · Jazz Pharmaceuticals (JAZZ)17 Form 4 lines · source: SEC Form 4
- Filed 12 December 2019 — 9 July 2026Director · BridgeBio Pharma (BBIO)34 Form 4 lines · source: SEC Form 4
- Filed 6 November 2018 — 3 June 2026Director · Denali Therapeutics (DNLI)19 Form 4 lines · source: SEC Form 4
Everything they disclosed
70 entries, newest first — one per disclosure report, one per Form 4 line- had shares withheld for tax on 14 shares of Jazz PharmaceuticalsSEC Form 42 September 2026Ordinary Shares · traded 31 August 2026 · filed 2 September 2026
- had shares withheld for tax on 1,692 shares of Jazz PharmaceuticalsSEC Form 42 September 2026Ordinary Shares · traded 31 August 2026 · filed 2 September 2026
- was granted 1,605 shares of Jazz PharmaceuticalsSEC Form 47 August 2026Ordinary Shares · traded 5 August 2026 · filed 7 August 2026
- exercised options over 19,000 shares of BridgeBio PharmaSEC Form 413 July 2026Common Stock · traded 9 July 2026 · filed 13 July 2026
- exercised options over 112,422 shares of BridgeBio PharmaSEC Form 413 July 2026Common Stock · traded 9 July 2026 · filed 13 July 2026
- exercised options over 17,167 shares of BridgeBio PharmaSEC Form 413 July 2026Common Stock · traded 9 July 2026 · filed 13 July 2026
- ▼ sold on the open market 36,167 shares of BridgeBio PharmaSEC Form 413 July 2026Common Stock · traded 9 July 2026 · filed 13 July 2026
- ▼ sold on the open market 112,422 shares of BridgeBio PharmaSEC Form 413 July 2026Common Stock · traded 9 July 2026 · filed 13 July 2026
- exercised options over 19,000 shares of BridgeBio Pharma (a derivative holding)SEC Form 413 July 2026Stock Option (Right to Buy) · traded 9 July 2026 · filed 13 July 2026
- exercised options over 112,422 shares of BridgeBio Pharma (a derivative holding)SEC Form 413 July 2026Stock Option (Right to Buy) · traded 9 July 2026 · filed 13 July 2026
- exercised options over 17,167 shares of BridgeBio Pharma (a derivative holding)SEC Form 413 July 2026Stock Option (Right to Buy) · traded 9 July 2026 · filed 13 July 2026
- was granted 3,990 shares of BridgeBio PharmaSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- ▼ sold on the open market 2,196 shares of BridgeBio PharmaSEC Form 424 June 2026Common Stock · traded 23 June 2026 · filed 24 June 2026
- exercised options over 20,000 shares of BridgeBio PharmaSEC Form 424 June 2026Common Stock · traded 24 June 2026 · filed 24 June 2026
- exercised options over 17,167 shares of BridgeBio PharmaSEC Form 424 June 2026Common Stock · traded 24 June 2026 · filed 24 June 2026
- ▼ sold on the open market 37,167 shares of BridgeBio PharmaSEC Form 424 June 2026Common Stock · traded 24 June 2026 · filed 24 June 2026
- was granted 5,277 shares of BridgeBio Pharma (a derivative holding)SEC Form 424 June 2026Stock Option (Right to Buy) · traded 22 June 2026 · filed 24 June 2026
- exercised options over 20,000 shares of BridgeBio Pharma (a derivative holding)SEC Form 424 June 2026Stock Option (Right to Buy) · traded 24 June 2026 · filed 24 June 2026
- exercised options over 17,167 shares of BridgeBio Pharma (a derivative holding)SEC Form 424 June 2026Stock Option (Right to Buy) · traded 24 June 2026 · filed 24 June 2026
- exercised options over 65,921 shares of BridgeBio PharmaSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- exercised options over 17,167 shares of BridgeBio PharmaSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- ▼ sold on the open market 88,737 shares of BridgeBio PharmaSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- ▼ sold on the open market 1,503 shares of BridgeBio PharmaSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- exercised options over 65,921 shares of BridgeBio Pharma (a derivative holding)SEC Form 417 June 2026Stock Option (Right to Buy) · traded 15 June 2026 · filed 17 June 2026
- exercised options over 17,167 shares of BridgeBio Pharma (a derivative holding)SEC Form 417 June 2026Stock Option (Right to Buy) · traded 15 June 2026 · filed 17 June 2026
- was granted 6,408 shares of Denali TherapeuticsSEC Form 45 June 2026Common Stock · traded 3 June 2026 · filed 5 June 2026
- was granted 19,226 shares of Denali Therapeutics (a derivative holding)SEC Form 45 June 2026Stock Option (right to buy) · traded 3 June 2026 · filed 5 June 2026
- was granted 3,507 shares of Jazz PharmaceuticalsSEC Form 411 August 2025Ordinary Shares · traded 7 August 2025 · filed 11 August 2025
- had shares withheld for tax on 1,805 shares of Jazz PharmaceuticalsSEC Form 411 August 2025Ordinary Shares · traded 8 August 2025 · filed 11 August 2025
- was granted 8,425 shares of BridgeBio Pharma (a derivative holding)SEC Form 424 June 2025Stock Option (Right to Buy) · traded 20 June 2025 · filed 24 June 2025
- was granted 6,589 shares of BridgeBio PharmaSEC Form 424 June 2025Common Stock · traded 20 June 2025 · filed 24 June 2025
- was granted 18,111 shares of Denali Therapeutics (a derivative holding)SEC Form 45 June 2025Stock Option (right to buy) · traded 3 June 2025 · filed 5 June 2025
- was granted 6,037 shares of Denali TherapeuticsSEC Form 45 June 2025Common Stock · traded 3 June 2025 · filed 5 June 2025
- was granted 3,731 shares of Jazz PharmaceuticalsSEC Form 46 August 2024Ordinary Shares · traded 2 August 2024 · filed 6 August 2024
- had shares withheld for tax on 1,484 shares of Jazz PharmaceuticalsSEC Form 46 August 2024Ordinary Shares · traded 6 August 2024 · filed 6 August 2024
- was granted 26,014 shares of BridgeBio Pharma (a derivative holding)SEC Form 425 June 2024Stock Option (Right to Buy) · traded 21 June 2024 · filed 25 June 2024
- ▼ sold on the open market 1,458 shares of Denali TherapeuticsSEC Form 410 June 2024Common Stock · traded 6 June 2024 · filed 10 June 2024
- was granted 17,901 shares of Denali Therapeutics (a derivative holding)SEC Form 44 June 2024Stock Option (right to buy) · traded 31 May 2024 · filed 4 June 2024
- was granted 5,967 shares of Denali TherapeuticsSEC Form 44 June 2024Common Stock · traded 31 May 2024 · filed 4 June 2024
- ▼ sold on the open market 417 shares of Jazz PharmaceuticalsSEC Form 46 December 2023Ordinary Shares · traded 4 December 2023 · filed 6 December 2023
- was granted 3,075 shares of Jazz PharmaceuticalsSEC Form 415 August 2023Ordinary Shares · traded 11 August 2023 · filed 15 August 2023
- ▼ sold on the open market 1,241 shares of Jazz PharmaceuticalsSEC Form 415 August 2023Ordinary Shares · traded 14 August 2023 · filed 15 August 2023
- was granted 51,501 shares of BridgeBio Pharma (a derivative holding)SEC Form 423 June 2023Stock Option (right to buy) · traded 21 June 2023 · filed 23 June 2023
- was granted 12,649 shares of Denali Therapeutics (a derivative holding)SEC Form 45 June 2023Stock Option (right to buy) · traded 1 June 2023 · filed 5 June 2023
- was granted 4,216 shares of Denali TherapeuticsSEC Form 45 June 2023Common Stock · traded 1 June 2023 · filed 5 June 2023
- exercised options over 3,576 shares of BridgeBio Pharma (a derivative holding)SEC Form 421 February 2023Restricted Stock Units · traded 16 November 2021 · filed 21 February 2023
- exercised options over 3,576 shares of BridgeBio PharmaSEC Form 421 February 2023Common Stock · traded 16 November 2021 · filed 21 February 2023
- ▼ sold on the open market 420 shares of Jazz PharmaceuticalsSEC Form 46 December 2022Ordinary Shares · traded 2 December 2022 · filed 6 December 2022
- was granted 2,561 shares of Jazz PharmaceuticalsSEC Form 49 August 2022Ordinary Shares · traded 5 August 2022 · filed 9 August 2022
- ▼ sold on the open market 1,089 shares of Jazz PharmaceuticalsSEC Form 49 August 2022Ordinary Shares · traded 8 August 2022 · filed 9 August 2022
- was granted 104,921 shares of BridgeBio Pharma (a derivative holding)SEC Form 424 June 2022Stock Option (right to buy) · traded 22 June 2022 · filed 24 June 2022
- was granted 17,959 shares of Denali Therapeutics (a derivative holding)SEC Form 46 June 2022Stock Option (right to buy) · traded 2 June 2022 · filed 6 June 2022
- was granted 5,986 shares of Denali TherapeuticsSEC Form 46 June 2022Common Stock · traded 2 June 2022 · filed 6 June 2022
- ▼ sold on the open market 417 shares of Jazz PharmaceuticalsSEC Form 46 December 2021Ordinary Shares · traded 2 December 2021 · filed 6 December 2021
- was granted 2,246 shares of Jazz PharmaceuticalsSEC Form 42 August 2021Ordinary Shares · traded 29 July 2021 · filed 2 August 2021
- was granted 38,895 shares of BridgeBio Pharma (a derivative holding)SEC Form 422 June 2021Stock Option (right to buy) · traded 17 June 2021 · filed 22 June 2021
- was granted 6,222 shares of Denali Therapeutics (a derivative holding)SEC Form 44 June 2021Stock Option (right to buy) · traded 2 June 2021 · filed 4 June 2021
- was granted 2,074 shares of Denali TherapeuticsSEC Form 44 June 2021Common Stock · traded 2 June 2021 · filed 4 June 2021
- exercised options over 3,253 shares of Denali TherapeuticsSEC Form 43 June 2021Common Stock · traded 1 June 2021 · filed 3 June 2021
- exercised options over 3,253 shares of Denali Therapeutics (a derivative holding)SEC Form 43 June 2021Restricted Stock Units · traded 1 June 2021 · filed 3 June 2021
- was granted 2,590 shares of Jazz PharmaceuticalsSEC Form 41 March 2021Ordinary Shares · traded 25 February 2021 · filed 1 March 2021
- was granted 6,475 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 41 March 2021Non-Qualified Stock Option (right to buy) · traded 25 February 2021 · filed 1 March 2021
- exercised options over 3,576 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 November 2020Restricted Stock Units · traded 16 November 2020 · filed 18 November 2020
- exercised options over 3,576 shares of BridgeBio PharmaSEC Form 418 November 2020Common Stock · traded 16 November 2020 · filed 18 November 2020
- was granted 15,183 shares of Denali Therapeutics (a derivative holding)SEC Form 45 June 2020Stock Option (right to buy) · traded 3 June 2020 · filed 5 June 2020
- was granted 3,253 shares of Denali Therapeutics (a derivative holding)SEC Form 45 June 2020Restricted Stock Units · traded 3 June 2020 · filed 5 June 2020
- was granted 112,422 shares of BridgeBio Pharma (a derivative holding)SEC Form 44 June 2020Stock Option (right to buy) · traded 2 June 2020 · filed 4 June 2020
- was granted 82,878 shares of BridgeBio Pharma (a derivative holding)SEC Form 416 December 2019Stock Option (right to buy) · traded 12 December 2019 · filed 16 December 2019
- was granted 27,245 shares of Denali Therapeutics (a derivative holding)SEC Form 431 May 2019Stock Option (right to buy) · traded 30 May 2019 · filed 31 May 2019
- was granted 50,044 shares of Denali Therapeutics (a derivative holding)SEC Form 48 November 2018Stock Option (right to buy) · traded 6 November 2018 · filed 8 November 2018
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.